| HOME >> BIOLOGY >> TECHNOLOGY |
ard-Looking Statements
This press release includes forward-looking statements. All statements
other than statements of historical facts included in this press release
that address activities, events or developments that we expect, believe or
anticipate will or may occur in the future are forward-looking statements
including, in particular, the statements about: our financial condition,
results of operations, prospects and business generally; expectations
regarding our ability to design and deliver innovative new noninvasive
technologies; and expectations for total revenues, including royalties,
product revenues and GAAP earnings per share for the full fiscal year 2008.
These forward-looking statements are based on management's current
expectations and beliefs and are subject to uncertainties and factors, all
of which are difficult to predict and many of which are beyond our control
and could cause actual results to differ materially and adversely from
those described in the forward-looking statements. These risks include, but
are not limited to, those related to: our reliance on Masimo SET and
related products and technologies for substantially all of our revenue; any
failure in protecting our intellectual property exposure to competitors'
assertions of intellectual property claims; the highly competitive nature
of the markets in which we sell our products and technologies; the failure
to continue developing innovative products and technologies; the lack of
acceptance of any new products and technologies of ours; obtaining
regulatory approval of our current and future products and technologies,
including the recently announced total hemoglobin measurement; the loss of
our customers the failure to retain and recruit senior management; product
liability claims exposure; a failure to obtain expected returns from the
amount of intangible assets we have recorded; the maintenance of our brand;
the impact of the decline in the U.S. credit markets on us and our
custo
'/>"/>
| SOURCE Masimo Corporation Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. New Clinical Studies Presented at the American Society of Anesthesiology (ASA) Annual Meeting Show Masimo Technologies Provide Advanced Clinical Intelligence
2. Five New Clinical Studies Show Value of Masimo PVI & PI
3. Masimo to Report Third Quarter 2008 Financial Results on October 27, 2008
4. Masimo Initiates Limited Release of First-Ever Noninvasive and Continuous Hemoglobin Monitors
5. Masimo Announces Desaturation Index 3D Alarm as Standard Feature in All Radical-7 Pulse CO-Oximetry Devices
6. Masimo to Present at Goldman Sachs 29th Annual Global Healthcare Conference
7. Masimo to Present at Deutsche Bank 33rd Annual Health Care Conference
8. Masimo Reports First Quarter 2008 Financial Results
9. Atom Medical Adopts Masimo Rainbow SET Technology
10. Schiller AG Adopts Masimo Rainbow SET as Their Technology Platform of Choice for Patient Monitoring Devices Worldwide
11. Masimo to Present at Citi Investment Research 5th Annual Small & Mid-Cap Conference
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |